Navigation Links
Damon Runyon Cancer Research Foundation awards prestigious fellowships to 17 top young scientists
Date:6/19/2009

uction is a hallmark of many forms of cancer.

Josselin Milloz, PhD, with his sponsor Sharad Ramanathan, PhD, at Harvard University, Cambridge, Massachusetts, aims to understand how autophagy, the process of cellular "self-cannibalism," is involved in a large number of cancers. Learning how autophagy is coordinated with other cellular processes will better elucidate its multiple roles in cancer.

Taiowa A. Montgomery, PhD, with his sponsor Gary Ruvkun, PhD, at Massachusetts General Hospital, Boston, Massachusetts, is studying mechanisms of gene silencing by a class of small regulatory molecules called microRNAs. In addition to having essential roles in development, microRNAs can act as oncogenes or as tumor suppressors. MicroRNAs have tremendous potential to be used therapeutically to prevent and treat cancer.

Benjamin R. Myers, PhD, with his sponsor Philip A. Beachy, PhD, at Stanford University, Stanford, California, is studying the function of the Hedgehog signaling pathway, in particular, how inappropriate activation of this pathway can lead to the initiation and growth of tumors. Insights into Hedgehog signaling may allow for the development of more potent and specific forms of cancer therapy.

Jared T. Nordman, PhD [HHMI Fellow] with his sponsor Terry L. Orr-Weaver, PhD, at the Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, is working to identify genes that are necessary to ensure accurate and efficient duplication of the genome. Identifying genes involved in the regulation of DNA replication is critical for understanding how a normal cell can become a tumor cell.

Sharsti L. Sandall, PhD, with her sponsor D. Leanne Jones, PhD, at the Salk Institute for Biological Studies, La Jolla, California, is investigating the mechanisms governing stem cell fate within the native environment or "niche." These studies may reveal paradigms of how a normal stem cell niche can be converted to an environment
'/>"/>

Contact: Yung S. Lie, Ph.D.
yung.lie@damonrunyon.org
212-455-0521
Damon Runyon Cancer Research Foundation
Source:Eurekalert

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. NYC Benefit Raises $1.4m for the Damon Runyon Cancer Research Foundation, Honors Merck
2. Reminder: Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium
3. Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium
4. The 2009 Damon Runyon-Rachleff Innovation Award Granted for Pioneering Ideas for Early Detection of Ovarian and Lung Cancers, Bone Marrow Transplant Safety, and Discovery of New Genetic Markers for Cancer
5. Damon Runyon Cancer Research Foundation awards $2.25M to 5 top young clinical investigators
6. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 14 top young investigators
7. Damons Grill Completes Move to Trans Fat-Free Menu
8. Mayo researchers: Dramatic outcomes in prostate cancer study
9. Moores UCSD Cancer Center Luau and Longboard Invitational Announce Dr. David Easter to Receive the 2009 Rell Sunn Queen of Makaha Award
10. Oncology Care Quality Improvement Program Introduced by Bipartisan Coalition Dedicated to Better Cancer Care Nationwide
11. Green Tea Component May Slow Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... Children’s Hospital from nearby hot tub company helps raise money ... ... Salt Lake City, UT (PRWEB) December ... the donation of a Bullfrog Spa to aid in fund ... City, Utah. Primary Children’s Medical Center, serving child patients from ...
(Date:12/16/2009)... sector revenue increased by 5.7 percent in 2008 ... 2007, according to new data from the U.S. ... North American Industry Classification System as NAICS 62. ... come from the 2008 Service Annual Survey: ... of tables which provides estimates of revenue, sources ...
(Date:12/16/2009)... 16 Smart Balance, Inc. (Nasdaq: SMBL ... authorized a two-year stock repurchase program of up to ... program demonstrates the confidence we have in the prospects ... long-term value for all of our shareholders, while at ... Stephen Hughes, Smart Balance, Inc. Chairman and Chief Executive ...
(Date:12/16/2009)... CHASE, Md., Dec. 16 New Enterprise ... firm, today announced that one of its portfolio ... agreement to be acquired by Ethicon, Inc., a ... for approximately $785 million (net of estimated cash ... technology company dedicated to designing, developing and commercializing ...
(Date:12/16/2009)... gain full benefit from breakthroughs, experts say, , , WEDNESDAY, ... lines currently used for research come mostly from white ... mean that non-whites will benefit less from any medical ... experts say. , Blacks could be especially affected. In ... lines studied showed any traces of recent African ancestry, ...
Breaking Medicine News(10 mins):Health News:Bullfrog Spas Helps Critically Ill Children 2Health News:Bullfrog Spas Helps Critically Ill Children 3Health News:Bullfrog Spas Helps Critically Ill Children 4Health News:Census Bureau: Health Care Industries Showed Modest Growth in Revenue in 2008 2Health News:Census Bureau: Health Care Industries Showed Modest Growth in Revenue in 2008 3Health News:Smart Balance Authorizes Stock Repurchase Program 2Health News:NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon 2Health News:NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon 3Health News:Most Stem Cells Used in Research Come From Whites 2
... of Texas, 181,legislators are being honored with the ... accomplishments on behalf of health care,during the 80th ... created the award in 1997 to honor state ... on issues important,to hospitals and health systems. ...
... WASHINGTON, Oct. 15 Arthur H. Rubenstein,MBBCh, executive vice ... medicine, and Robert G. Dunlop professor of medicine at ... board of directors of the,Association of Academic Health Centers., ... School of Medicine in New,York before assuming his current ...
... pose big stomach risks, study notes , , MONDAY, ... don,t tell their doctors that they take common over-the-counter ... omission, a new study has found. , "With nearly ... it is no wonder that adverse events are increasing ...
... PA and VANCOUVER, BC, Oct. 15 /PRNewswire/ - ... pain drugs, announced today it has successfully reached ... (FDA) under the,Special Protocol Assessment (SPA) process for ... (OROS(R) Hydromorphone) for the treatment of,chronic pain. A ...
... Calif., Oct. 15 Edwards Lifesciences,Corporation (NYSE: EW ... advanced cardiovascular disease, plans to announce its operating,results for ... closes on,Monday, October 22, 2007 and will host a ... its results. To participate in the conference call, ...
... by gift from P&G, PHILADELPHIA, Oct. 15 ... for Clinical Research & Education,today announced a commitment ... gift to the ACG Institute,s Capital Campaign boosts ... in more than $16 million to,support clinical research, ...
Other Medicine News:Health News:THA Honors Nine Legislators for Contributions to Health Care 2Health News:Association of Academic Health Centers Names University of Pennsylvania's Dr. Arthur H. Rubenstein Chairman of the Board of Directors 2Health News:Many Patients Don't Report Use of OTC Pain Drugs 2Health News:Many Patients Don't Report Use of OTC Pain Drugs 3Health News:Neuromed Concludes a Special Protocol Assessment (SPA) with FDA for a Pivotal Phase 3 Study on NMED-1077 2Health News:Neuromed Concludes a Special Protocol Assessment (SPA) with FDA for a Pivotal Phase 3 Study on NMED-1077 3Health News:Edwards Lifesciences to Host Earnings Conference Call on October 22, 2007 2Health News:ACG Announces Generous Gift by Procter & Gamble 2
(Date:12/16/2009)... 16 HealthWarehouse.com, Inc. (OTC Bulletin Board: HEWA) ... secured $1 million in 12% per annum short term ... is an initial drawdown of $500,000, with accrued interest ... of $500,000 with accrued interest and principal repayable in ... Company becoming cashflow positive for any calendar month prior ...
(Date:12/16/2009)... December 16 Scientists at,deCODE genetics, Inc. ... the,discovery of a version of a common single-letter ... with a major impact on susceptibility to type ... is not only large, but unusual:,if an individual ... risk of,T2D by more than 30% compared to ...
(Date:12/16/2009)... Wis., Dec. 16 EuroPharma, Inc. ... for the use of super absorbency BCM-95® ... EuroPharma formulations. The exclusive distribution territory ... health food store channel and professional channel, ... and clinics. BCM-95® is a highly ...
Breaking Medicine Technology:HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 3deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 4EuroPharma Exclusive Distributor of BCM-95 and BosPure 2EuroPharma Exclusive Distributor of BCM-95 and BosPure 3Kansas Bioscience Authority Commits 2450 Million to Increase Venture Capital Accelerate Bioscience Business Growth 14408 1Kansas Bioscience Authority Commits 2450 Million to Increase Venture Capital Accelerate Bioscience Business Growth 14408 2Kansas Bioscience Authority Commits 2450 Million to Increase Venture Capital Accelerate Bioscience Business Growth 14408 3Award recognizes 30 years of anti smoking work 59213 1Award recognizes 30 years of anti smoking work 59213 2Developing enzymes to clean up pollution by explosives 10312 1
... Results presented at the Movement Disorder Society's 11th,International ... 08, 2007 /PRNewswire-FirstCall/ -- New,information on the use ... disease (PD) was reported this week at The,Movement ... approved by the FDA May 17, 2006, for ...
... 8, 2007 - AVANIR,Pharmaceuticals (NASDAQ:AVNR) today ... including efficacy, safety and improvements in,patient-centered ... (DPN) pain treated with the investigational ... and sigma-1 agonist. The data were ...
Other Medicine Technology:International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 2International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 3International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 4International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 5International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 6AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 2AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 3AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 4AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 5AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 6AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 7
Kevorkian Endocervical Curette is a stainless-steel curette with a basket. It is narrow tipped for sampling without dilation....
Available in 5, 8 and 12 mm bite, with and without teeth....
...
...
Medicine Products: